Black Diamond Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
BDTX Company Description
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
BDTX Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view BDTX Smart Score
Score Breakdown
BDTX Company Description
Show More
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of BDTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by BDTX's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
WallStreetBets
Number of mentions of BDTX in WallStreetBets Daily Discussion
BDTX News
Recent insights relating to BDTX
CNBC Recommendations
Recent picks made for BDTX stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in BDTX
Corporate Flights
Flights by private jets registered to BDTX
Our Analysis